ResearcherStanford MedicineNo recent work listed
Muthuraman Alagappan
Matched on ORCID iD 0000-0003-3224-7369; OpenAlex author ID A5014879891. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper
Papers 3
- Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT. Co-author DOI 10.1097/coc.0000000000000263↗
- Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Ca… Co-author DOI 10.1016/j.ijrobp.2016.04.034↗
- Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. First author DOI 10.1016/j.ijrobp.2014.06.066↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Albert C. Koong · 3 shared papers, 2014–2018 · strength 0.18
- Paper Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With … DOI 10.1097/coc.0000000000000263↗
- Paper Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biom… DOI 10.1016/j.ijrobp.2016.04.034↗
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Erqi Liu Pollom · 3 shared papers, 2014–2018 · strength 0.18
- Paper Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With … DOI 10.1097/coc.0000000000000263↗
- Paper Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biom… DOI 10.1016/j.ijrobp.2016.04.034↗
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Daniel Tandel Chang · 3 shared papers, 2014–2018 · strength 0.18
- Paper Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With … DOI 10.1097/coc.0000000000000263↗
- Paper Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biom… DOI 10.1016/j.ijrobp.2016.04.034↗
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- George A. Poultsides · 2 shared papers, 2014–2018 · strength 0.12
- Paper Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With … DOI 10.1097/coc.0000000000000263↗
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Margaret M. Kozak · 1 shared paper, 2018 · strength 0.09
- Ruijiang Li · 1 shared paper, 2016 · strength 0.06
- Yi Cui · 1 shared paper, 2016 · strength 0.06
- James M. Ford · 1 shared paper, 2014 · strength 0.04
- Brendan Christopher Visser · 1 shared paper, 2014 · strength 0.04
- Aya Kamaya · 1 shared paper, 2014 · strength 0.04
- Pamela L. Kunz · 1 shared paper, 2014 · strength 0.04
- Jeffrey Allen Norton · 1 shared paper, 2014 · strength 0.04
- George Albert Fisher · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.